The effect of β-blocker on hamster model BIO 53.58 with dilated cardiomyopathy determined using 123I-MIBG myocardial scintigraphy

Annals of Nuclear Medicine

Volumn 17, Issue 8, 2003, Pages 677-683

  Inoue, Aritomo ^a   Yamashina, Shohei ^a   Yamazaki, Junichi ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BIO 53.58 hamster; DCM; MIBG; blocker

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DOPAMINE; METOPROLOL; NORADRENALIN;

ADOLESCENT; ADRENALIN BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLEARANCE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPAMINE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; GENETIC STRAIN; HAMSTER; HAMSTER BIO 53.58; HEART; HEART INNERVATION; HEART LEFT VENTRICLE MYOCARDIAL WASHOUT RATIO; HEART MUSCLE FIBROSIS; HEART SCINTISCANNING; MALE; MEDIASTINUM; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SCINTILLATION COUNT RATIO; SCINTILLATION COUNTING; SYMPATHETIC FUNCTION;

EID: 1042291319     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984974     Document Type: Article

References (28)

1. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-1036.
2. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979; 1: 1374-1376.
3. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J 1980; 44: 117-133.
4. Heilbrunn SM, Shah P, Bristow MR, Valantine HA, Ginsburg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79: 483-490.
5. Wieland DM, Brown LE, Rogers WL, Worthington KC, Wu JL, Clithorne NH, et al. Myocardial imaging with radioiodinated norepinephrine storage analog. J Nucl Med 1981; 22: 22-31.
6. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt E, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981; 22: 129-132.
7. 123I-MIBG by polar map in patients with dilated cardiomyopathy. Nucl Med Commun 1997; 18: 219-229.
8. Michels VV, Moll PP, Miller FA. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992; 326: 77-82.
9. Waagstein F, Bristow MR, Swedberg K, Erdmann E, Remme WJ, Cleland JG, et al. Metoprolol in Dilated Cardiomyopathy (MDC Trial Study Group): Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993; 342: 1441-1446.
10. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure. The cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994; 90: 1765-1773.
11. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS II); a randomized trial. Lancet 1999; 353: 9-13.
12. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol: CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007.
13. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355.
14. Yamada S, Ohkura T, Yamada T, Ito O, Kimura R, Nozawa Y, et al. Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by Metoprolol treatment. J Pharmacol Exp Ther 1997; 283 (5): 1389-1395.
15. Sakamoto A, Ono K, Abe M. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 1997; 94: 13873-13878.
16. Urasawa K, Sato K, Igarashi Y, Kawaguchi H, Yasuda H. A mechanism of catecholamine tolerance in congestive heart failure-alterations in the hormone sensitive adenylyl cyclase sysytem of the heart-. Jpn Circ J 1992; 56: 456-461.
17. Taguchi T, Kobayashi A, Kurata C, Tawarahara K, Yamazaki N. Dual-tracer autoradiography with thallium-201 and iodine-125 MIBG in Bio 14.6 cardiomyopathic Syrian hamsters. Jpn Circ J 1993; 57: 1089-1096.
18. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Rande JL, Syrota A, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40: 917-923.
19. Merlet P, Vallete H, Dubois-Rande J-L. Prognostic value of cardiac meta-iodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33: 471-477.
20. Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjyo S, Inoue A. Evaluation of β-blocker therapy in patients with dilated cardiomyopathy-Clinical meaning of Iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001; 141: 645-652.
21. 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of β-blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment. Heart 1999; 81: 148-152.
22. Suwa M, Otake Y, Moriguchi A. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 1997; 133: 353-358.
23. Takatsu H, Uno Y, Fujisawa H. Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic syrian hamsters using the renin-angiotensin system. J Nucl Med 1995; 36: 1055-1061.
24. Wakabayashi Y, Kurata C, Mikami T, Shouda S, Okayama K, Tawarahara K. Effects of cilazapril and verapamil on myocardial iodine-125-metaiodobenzylguanidine accumulation in cardiomyopathic BIO 53.58 hamsters. J Nucl Med 1997; 38: 1540-1545.
25. Eisenhofer G, Friberg P, Rundqvist B, Quyyumi A, Lambert GW, Goldstein DS, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996; 93: 1667-1676.
26. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation 1993; 37: 855-862.
27. 201T1 in congestive heart failure. Nucl Med Commun 1996; 17: 225-230.
28. Marco M, Raffaele G, Savina N, Emiliano B, Maria GM, Livio DC. Differential effects of β-blockers in patients with heart failure. A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 2000; 102: 546-551.